AURO-TADALAFIL

auro pharma inc🇨🇦 Health Canada

Approval Id: 05276666329d2e75
Drug Approval Canada Name: AURO-TADALAFIL
Product Name: AURO-TADALAFIL
Status: Marketed
Status Date: 2016-07-14
Original Market Date: 2016-07-14
Din: 02435926
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485004
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

TADALAFIL

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

05276666329d2e75

Type

Standard